From: Phase I dose-escalation oncology trials with sequential multiple schedules
Doses in mg | ||||||
---|---|---|---|---|---|---|
Scenario | 2.5 | 5 | 7.5 | 10 | 12.5 | 15 |
1 | 0.05 | 0.10 | 0.20 | 0.30 | 0.50 | 0.70 |
2 | 0.30 | 0.40 | 0.52 | 0.61 | 0.76 | 0.87 |
3 | 0.05 | 0.06 | 0.08 | 0.11 | 0.19 | 0.34 |
4 | 0.06 | 0.08 | 0.12 | 0.18 | 0.40 | 0.71 |
5 | 0.10 | 0.22 | 0.31 | 0.45 | 0.60 | 0.72 |
6 | 0.50 | 0.55 | 0.61 | 0.69 | 0.76 | 0.87 |